APLICACIÓN DE LAS TÉCNICAS INMUNOHISTOQUÍMICAS AL ESTUDIO DE
LOS SÍNDROMES LINFOPROLIFERATIVOS
Dr. Tomás Álvaro Naranjo, Dr.
Ramón Bosch Príncep, Dra. Salomé Martínez González, Dra. Mª Teresa Salvadó Usach
12.- Bibliografía
Volver al Índice
Bibliografía
- Alavaikko MJ, Blanco G, Aine R, Lehtinen T, Fellbaum C, Taskinnen PJ, Sarpola A,
Hansmann ML. Follicular dendritic cells have prognostic relevance in Hodgkin's disease. Am
J Clin Pathol 1994;101:761-767.
- Álvaro Naranjo T, ed. 1er Curso de Hematopatología. Tortosa: Inst Cat Salut, 1994.
- Álvaro Naranjo T, ed. 2º Curso de Hematopatología. Tortosa: Inst Cat Salut, 1995.
- Álvaro T. Factores técnicos en el estudio de síndromes linfoproliferativos. En:
Álvaro Naranjo, Segundo Curso de Hematopatología, Tortosa, Inst. Cat. Salut, 1995.
- Alvaro T, Font L, Contreras E, Gonzalez S, Izuel JA, Sirvent JJ. Linfoma de alto grado
de malignidad de tejido linfoide asociado a las mucosas del estómago. Patología 1995;
28: 265-269.
- Álvaro T, Bosch R, Salvadó MT, Piris MA. True histiocytic lymphoma of the stomach
associated with low-grade B-cell Mucosa Associated Lymphoma tissue (MALT)-Type lymphoma.
American Journal of Surgical Pathology. 1996: 20: 1406-1411.
- Álvaro-Naranjo T, Salvadó-Usach MT, Bosch-Príncep R, Martínez-González S. P53 en
enfermedad de Hodking. Med Clin (Barc) 1996; 10: 398-399.
- Alvaro-Naranjo T, Salvadó-Usach T, Font-Ferré L, Gumà-Padrò J, Bosch-Príncep R,
Contreras-Barbeta E.Significado pronòstico de la proteína P53 en la enfermedad de
Hodgkin. Neoplasia 1996;13:1-4.
- Álvaro T; Salvadó Mt; Martínez S; Bosch R; Risa R; Barberá M. Desenmascaramiento
antigénico no enzimático. Estudio comparativo entre horno microondas y olla a presión
en secciones de tejido fijadas en formol e incluidas en parafina. PATOLOGÍA 1996; 29:
217-225.
- Álvaro T, Bosch R, Martínez S, Salvadó MT ed. Tercer Curso de Hematopatología.
Tortosa: Inst Cat Salut, 1996.
- Álvaro T; Piris MA; Campo E. Factores técnicos, de estudio y de diagnóstico aplicados
a la patología linfoide. Encuesta a 47 patólogos españoles. PATOLOGIA 1996; 29:319-324.
- Álvaro Naranjo T., editor. Tercer Curso de Hematopatología, edición multimedia en
CD-ROM. Tortosa, Inst. Cat. Salut, 1996.
- Álvaro Naranjo T., editor. Cuarto Curso de Hematopatología, edición multimedia en
CD-ROM. Tortosa, Inst. Cat. Salut, 1997.
- Álvaro T. Metodología de trabajo en el estudio de síndromes linfo- y
mieloproliferativos. Errores más comunes, sus consecuencias y forma de corregirlos.
Tutorial de Patología Linfoide, Sevilla, 1997; 1: 26-43.
- Álvaro T, Font Ll, Bosch R, Salvadó MT, Guma J, ed. Cuarto Curso de
Hematopatología. Tortosa: Inst Cat Salut, 1997.
- Álvaro T, García B. Clasificación de la Organización Mundial de la Salud de los
tumores del tejido hematopoyético y linfoide. Adaptación y resumen. En: Álvaro T, Font
Ll, Bosch R, Salvadó MT, Guma J. Cuarto Curso de Hematopatología. Tortosa: Inst
Cat Salut, 1997, pp: 77-125.
- Álvaro T; Bosch R; Salvadó M; Barbera M; Risa R. Ausencia de correlación de
p53, bcl-2 y ki 67 entre linfomas no hodgkin y neoplasias primarias múltiples. Neoplasia
1997; 14: 100-104.
- Andrade RE, Wick MR, Frizzera G. Immunophenotyping of hematopoietic malignancies in
paraffin section. Hum Pathol 1988;19:394-402.
- Arber D, Weiss L. CD15: a review. Appl Immunohistochem 1993;1:17-30.
- Arber D, Weiss L. CD43: a review. Appl Immunohistochem 1993;1: 88-96.
- Arber D, Weiss L. CD5: a review. Appl Immunohistochem 1995; 3: 1-22.
- Arber D, Weiss L. CD57: a review. Appl Immunohistochem 1995; 3: 137-152.
- Arber D, Weiss L. CD10: a review. Appl Immunohistochem 1997; 5: 125-140.
- Armitage JO, Vose JM, Linder J, Weisenburger D, et al. Clinical significance of
immunophenotype in diffuse aggressive non-Hodgkins lymphoma. J Clin Oncol
1989;17:1783-1790.
- Banks PM, Chan J, Cleary ML, Delsol G, et al. Mantle cell lymphoma. A proposal for
unification of morphologic, immunologic, and molecular data. Am J Surg Pathol
1992;16:637-640.
- Bellas C, Santón A, Plaza G. Virus Epstein-Barr (VEB) y neoplasia. en: Álvaro T, Font
Ll, Bosch R, Salvadó MT, Guma J. Cuarto Curso de Hematopatología. Tortosa: Inst
Cat Salut, 1997, pp: 37-48.
- Bellas C, Santón A, Manzanal A, Campo E, Martín C, Acevedo A et al. Pathological,
immunological, and molecular features of Hodgkin´s disease associated with HIV infection:
comparison with ordinary Hodgkin´s disease. Am J Surg Pathol 1996; 20: 1520-1524.
- Brousset P, Imadalou K, Rubie H, Delsol-Tahou M, Selves J, Robert A, Delsol G.
Paraffin-section immunohistochemistry of residual disease in the testis in patients with
acute lymphoblastic leukemia using anti-mb-l/CD79a (JCB117) monoclonal antibody. Applk
Immunohist 1996; 4: 56-60.
- Browne G, Tobin B, Carney D, Dervan P. Aberrant MT2 positivity distinguishes follicular
lymphoma from reactivite follicular hyperplasia in B5- and formalin-fixed paraffin
sections. Am J Clin Pathol 1991;96:90-94.
- Brynes RK, McCourty A, Tamayo R, Jenkins K, Battifora H. Demonstration of cyclin D1
(Bcl-1) in mantle cell lymphoma. Enhanced staining using heat and ultrasound epitope
retrieval. Appl Immunohistochem 1997; 5: 45-48.
- Cabacadas J, Isaacson P. Phenotyping of T-cell lymphomas in paraffin sections-which
antibodies? Histopathology 1991;19:419-424.
- Campo E; Alvaro T. El sistema inmune. Estructura y función. Pag. 59-72, en: Álvaro
Naranjo, Primer Curso de Hematopatología, Tortosa, Inst. Cat. Salut, 1994.
- Cattoreti G, Pileri S, Parravivini C, et al. Antigen unmasking on formalin-fixed,
paraffin-embedded tissue sections. J Pathol 1993;171:83-98.
- Cibull M, Stein H, Gatter K, Masson D. The expression of the CD3 antigen in
Hodgkins disease. Histopathology 1989;15:597-605.
- Colecchia M, Frigo B, Leopardi O. CD57 antigen. Letters to the editor. Appl
Immunohistochem 1996; 4: 217-218.
- Coles F, Cartun R, Pastuszak W. Hodgkins disease, lymphocyte-predominant type:
immunoractivity with B-cell antibodies. Mod Pathol 1988;1:274-285.
- Davey R, Elghetany M, Kurec A. Immunophenotyping of hematologic neoplasms in
paraffin-embedded tissue sections. Am J Clin Pathol 1990:93(Suppl 1):S17-S26.
- Cossman J, Jaffe E, Fisher RI.Immunologic phenotypes of diffuse, aggressive,
non-Hodgkins lymphomas: Correlation with clinical features. Cancer
1984;54:1310-1317.
- Chan JKC, Ng CS, Hui PK. A simple guide to the terminology and application of leucocyte
monoclonal antibodies. Histopathology 1988;12:146-480.
- Chan WC. The t(2;5) or NPM-ALK translocation in lymphomas: diagnostic considerations.
Advances in Anatomic Pathology 1996; 3: 396-399.
- Chang KL, Arber DA, Weiss LM. CD20: a review. Appl Immunohistochem 1996;4:1-15.
- Chetty R, Biddolph S, Kaklamanis L, Kremmer E, Cary N, Stewart S et al.
Immunohistochemical demonstration of Epstein-Barr virus nuclear antigens 1 and 2 in
post-transplant lymphoproliferative disorders. Appl Immunohist 1996; 4: 102-105.
- Chetty R, Dada MA, Gatter KC. bcl-2: Longevity personified! Advances in Anatomic
Pathology 1997; 4: 134-138.
- Chetty R, O´Leary JJ, Gatter KC. Immunocytochemistry as a diagnostic tool. Current
Diagnostic Pathology 1995; 2: 38-45.
- Chetty R, O´Leary JJ, Biddolph SC, Gatter KC. Immunohistochemical detection of p53 and
bcl-2 proteins in Hashimoto´s thyroiditis and primary thyroid lymphomas. J Clin Pathol
1995; 48: 239-241.
- Chilosi M, Mobello A, Scarpa A. Combined immunohistochemical evaluation of expression of
p53 antioncogene, Epstein-Barr virus and CD30 antigens in Hodgking disease and anaplastic
large cell lymphomas. Patologia 1992; 25: 158A.
- Chilosi M, Pizzolo G. review of terminal deoxynucleotidyl transferase. Biological
aspects, methods of detection and selected diagnostic applications. Appl Immunohist 1995;
3: 209-221.
- Chittal S, Caveriviere P, Schwarting R, et al. Monoclonal antibodies in the diagnosis of
Hodgkins disease. The search for a rational panel. Am J Surg Pathol 1988;12:9-21.
- Chittal S, Al Saati T, Delsol G. Epithelial membrane antigen in hematolymphoid
neoplasms. A review. Appl Immunohist 1997; 5: 203-215.
- Dhir RK, Nalesnik MA, Demetris AJ, Randhawa PS. Latent membrane protein expression in
posttransplant lymphoproliferative disease. Appl Immunohist 1995; 3: 123-126.
- Dierlamm J, Pittaluga S, Wlodarska I, Stul M, Thomas J, Boogaerts M, et al. Marginal
zone B-cell lymphomas of different sites share similar cytogenetic and morphologic
features. Blood 1996; 87: 299:307.
- Dorfman DM, Pinkus GS. Utility of immunophenotipic studies in the diagnosis of low-grade
lymphoma of MALT and other low-grade non-Hodgkin´s lymphomas of extranodal sites. Appl
Immunohist 1995; 3: 160-167.
- Dorfman DM, Pinkus GS. CD99 (p30/32MIC2 ) immunoreactivity in the
diagnosis of thymic neoplasms and mediastinal lymphoproliferative disorders. A study of
paraffin sections using monoclonal antibody O13. Appl Immunohist 1996; 4: 34-42.
- Elghetany MT, Kurec AS, Shuehkler K, Forbes BA, Duggan DB, Davey FR. Immunophenotyping
of non-Hodgkings lymphomas in paraffin-embedded tissue sections: A comparison with
genotypic analysis. Am J Clin Pathol 1991:95:517-525.
- Falini B, Pileri S, Stein H, et al. Variable expression of leukocyte-common (CD45)
antigen in CD30 (Ki1)-positive anaplastic large -cell lymphoma: implications for the
diagnosis between lymphoid and non-lymphoid malignances. Hum Pathol 1990;21:624-9.
- Fleming MD, Shahsafaei A, Dorfman DM. Absence of dendritic reticulum cell staining is
helpful in distinguishing T-cell-rich B-cell lymphoma from lymphocyte predominance
Hodgkin´s disease. Appl Immunohist 1998; 6: 16-22.
- Gaulard P, dAgay MF, Peuchmaur M, et al Expression of the bcl-2 gene product in
follicular lymphoma. Am J Pathol 1992;140:1089-95.
- Gerdes J. Ki-67 and other proliferations markers useful for immunohistological
diagnostic and prognostic evaluations in human malignancies. Semin Cancer Biol
1990;1:199-206.
- González GL, Medeiros LJ, Jaffe ES. Composite lymphoma: A clinicopathologic analysis of
nine patients with Hodgkins disease and B-cell Hodgkins lymphoma. Am J Clin
Pathol 1991;96:81-89.
- Grogan, TM, Lippman SM, Spier CM, Slymen DJ, Rybski JA, Rangel CS, Richter LC, Miller
TP. Independent prognostic significance of a nuclear proliferation antigen in diffuse
large cell lymphomas as determined by the monoclonal antibody Ki-67. Blood
1988;71:1157-1160.
- Harris NL, Jaffe ES, Stein H et al. A Revised European-American Classification of
lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood
1994;84:1359-1360.
- Harris NL. Diagnosis and classification of lymphomas. En Colvin RB, BhanAK, McKluskey
RT. Diagnostic Immunopathology. New YorK: Raven Press, 1995:501-534.
- Hastrup N, Ralfkiaer E, Pallesen G. Aberrant phenotypes in peripheral T cell lymphomas.
J Clin Pathol 1989;42:398-402.
- Hess E, Cohen C, DeRose PB, Yost BA, Costa MJ. Nonspecificity of p30/32MIC2
immunolocalization with the 013 monoclonal antibody in the diagnosis of Ewing's sarcoma:
application of an algorithmic immunohistochemical analysis. Appl Immunohistochem 1997; 5:
94-103.
- Horning SJ, Doggett RS, Warnke RS, Dorfman RA, Fox RF, Cox RS, Levy R. Clinical
relevance of immunologic phenotype in diffuse large cell lymphoma. Blood 1984;
63:1209-1215.
- Ioachim HL, Dorsett B, Cronin W, Maya M, Wahl S. Acquired immunodeficiency
syndrome-associated lymphomas: Clinical, pathologic, immunologic, and viral
characteristics of 111 cases. Hum Pathol 1991;22:659-673.
- Isaacson PG, Piris MA. Splenic Marginal Zone Lymphoma. Advances in Anatomic Pathology,
1997; 4: 191-201.
- Jaffe ES, Zarate-Osorno, A, Medeiros LJ. The interrelationship of Hodgkins disease
and non-Hodgkins lymphomas-lessons learned from composite and sequential
malignances. Semin Diagn Pathol 1992;9:297-303.
- Jaffe ES. The role of immunophenotypic markers in the classification of
non-Hodgkins lymphomas. Semin Oncol 1990;17:11-19.
- Kadin M, Muramoto L; Said J. Expression of T cell antigens on Reed-Sternberg cells in a
subset of patients with nodular sclerosis and mixed cellularity Hodgkins disease. Am
J Pathol 1988;130:345-353.
- Kadin ME, Muramoto L, Said J. Expression of T-cell antigens on Reed-Sternberg cells in a
subset of patientes with nodular sclerosing and mixed cellularity Hodgkins disease.
Am J Pathol 1988;130:345-353.
- Kamel OW, Gelb AB, Shibuya RB, Warke RA. Leu7 (CD57) reactivity distinguishes nodular
lymphocyte predominance Hodgkins disease from nodular sclerosing Hodgkins
disease, T cell rich B cell lymphoma and follicular lymphoma. Am J Pathol 1993:142:541-6.
- Kamel OW, LeBrun DP, Davis RE, Berry GJ, Warnke RA. Growth fraction estimation of
malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/cyclin
19ª2: Correlation with Ki-67 labeling. Am J Pathol 1991;138:1471-1477.
- Kant JA. Molecular diagnostic approaches to lymphoid neoplasia. What´s possible and
what´s useful. Pathol Case Reviews 196; 1: 124-134.
- Leoncini L, Del Vecchio M, Kraft R, et al. Hodgkins disease and CD30-positive
anaplastic large cell lymphomas-a continuous spectrum of malignant disorders. Am J Pathol
1990;137:1047-1057.
- Leong ASY, Milios J, Leong FJ. Epitope retrieval with microwaves. A comparison of
citrate buffer and EDTA with three commercial retrieval solutions. Appl Immunohistochem
1996; 4: 201-207.
- Lippman SM, Miller TP, Spier CM, Slymen DJ and Grogan TM. The pronostic significance of
the immunotype in diffuse large-cell lymphoma: A proposal comparative study of the T-cell
and B-cell phenotype. Blood 1988;72:436-441.
- Lippman SM, Spier CM, Miller TP, Slymen DJ, Rybski JA, Grogan TM. Tumor-infiltrating
T-lymphocytes in B-cell diffuse large cell lymphoma-related to disease course. Mod Pathol
1990;3:361 -367.
- Medeiros L, Harmon D, Linggood R, Harris N. Immunohistologic features predict clinical
behavior of orbital and conjuntival lymphoide infiltrates. Blood 1989;74:2121-2129.
- Medeiros LJ, Picker LJ, Gelb AB, Strickler JG, Brain SW, Weiss LM, Horning SJ, Warnke
RA. Numbers of host "helper " T cells and proliferating cells predict survival
in diffuse small-cell lymphomas. J Clin Oncol 1989;7:1009-1017.
- Ngan B, Chen-Levy Z, WeissLM, Warnke RA, Cleary M. Expression in non-Hodgkins
lymphoma of bcl-2 protein associated with the t(14:18) chromosomal traslocation. N England
J Med 1988;318:1638-1644.
- Norton A, Isaacson P. Lymphoma phenotyping in formalin-fixed and paraffin wax-embedded
tissues: II. Profiles of reactivity in various tumor types. Histopathology
1989;14:557-579.
- Orazi A, Jiang B, Lee C-H, English GW, Cattoretti G, Hohn K et al. Correlation between
presence of clonal rearrangements of immunoglobulin heavy chain genes and B-cell antigen
expression in Hodgkin´s disease. Am J clin Pathol 1995; 104: 413-418.
- Pallesen G, Hamilton Ds, Rowe M, Young LS. Expression of Epstein-Barr virus latent gene
products in tumor cells of Hodgkins disease. Lancet 1991;337:320-2.
- Pezzella F, Morrison H, Jones M, Gatter KC, Lane D, Harris AL, Mason DY.
Immunohistochemical detection of p53 and bcl-2 proteins in non-Hodgkin's lymphoma.
Histopathology 1993; 22: 39-44.
- Pezzella F, Tse A, Cordell J, Pulford, Gatter K, Mason D. Expression of the Bcl-2
oncogene protein is not specific for 14-18 chromosomal translocation. Am J Surg Pathol
1990;137:225-232.
- Piris MA. Patrones inmunohistológicos básicos en las proliferaciones del ganglio
linfático. En: Álvaro Naranjo T. 2º Curso de Hematopatología. Tortosa: Inst Cat Salut,
1995, pp. 69-77.
- Piris M, Brown DC, Gatter KC, et al: CD30 expression in non-Hodgkins lymphoma.
Histopathology 1990;17:211-218.
- Prokocimer M, Shaklai M, Bassat HB, Wolf D, Goldfinger N, Rotter V. Expression of p53 in
human leukemia and lymphoma. Blood 1986; 68: 113-118.
- Robins DB, Katz RL, Swan F Jr, Atkinson EN, Ordoñez NG, Huh YO. Immunotyping of
lymphoma by Fine-needle Aspiration: a comparative study of cytospin preparations and flow
cytometry. Am J Clin Pathol 1994; 101: 569-576.
- Scoazec JY, Berger F, Mogaud JP, Brochier J, Coiffier B, Byron P. The dendritic
reticulum cell pattern in B cell lymphomas of the small cleaved, mixed and large cell
types. An immunohistochemical study of 48 cases. Hum Pathol 1989;20:124-131.
- Schlossman SF, Boumsell, Gilks W et al. Leucocyte typing V: White cell differentiation
antigens. Oxford: Oxford University Press, 1995.
- Schmid C, Pan L, Diss T, Issacson P. Expression of B-cell antigens by Hodgkins and
Reed-Sternberg cells. Am J Pathol 1991;139:701-707.
- Schwartr BR, Pinkus G, Bacus S, Toder M, Weinberg DS. Cell proliferation in
non-Hodgkin's lymphomas: Digital image analysis of Ki-67 antibody staining. Am J Pathol
1989;134:327-336.
- Segal GH. Assesment of B-cell clonality by the Polymerase Chain Reaction: a pragmatic
overview. Advances in Anatomic Pathology 1996; 3: 195-203.
- Shiota M, Fujimoto J, Takenaga M, Satoh H, Ichinohasama R, Abe M, et al. Diagnosis of
t(2;5) (p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. Blood 1994; 84:
3648-3652.
- Shipley WR, Hammer RD, Lennington WJ, Macon WR. Paraffin immunohistochemical detection
of CD56, a useful marker for neural cell adhesion molecule (NCAM), in normal and
neoplastic fixed tissues. Appl Immunohistochem 1997; 5: 87-93.
- Suchi T, Lennert K, Tu L, Kikuchi M, Sato E, Stansfeld AG, Feller AC. Histopathology and
immunohistochemistry of peripheral T cell lymphomas: A proposal for their classification.
J Clin Pathol 1987;40:995-1015.
- Smoller BR, Bishop K, Glusac EJ, Kim YH, Bhargava V, Warnke RA. Reassessment of
lymphocyte immunophenotyping in the diagnosis of patch and plaque stage lesions of mycosis
fungoides. Appl Immunohist 1995; 3: 32-36.
- Smoller BR, Bishop K, Glusac EJ, Bhargava V, Kim YH, Warnke RA. Lymphocyte antigen
abnormalities in inflammatory dermatoses. Appl Immunohist 1995; 3: 127-131.
- Stein H, Mason DY, Gerdes J, et al. The expression of Hodgkins disease associated
antigen ki-1 in reactive and neoplastic lymphoid tissue. Evidence that the Reed-Sternberg
cells and histiocytic malignancies are derived from activated lymphoid cells. Blood
1985;66:848.
- Strickler JG, Copenhaver CM, Rojas VA, Horning SJ, Warnke RA. Comparison of "host
cell infiltrates" in follicular lymphoma patients with and without spontaneous
regression. Am J Clin Pathol 1988;90:257-261.
- Sun T, Susin M. Differential diagnosis of lymphoid disorders. New York: Igaku-Shoin,
1995.
- Sundeen JT, Longo DL, Jaffe ES. CD5 expression in B-cell small lymphocytic malignances.
Correlations with clinical presentation and sites of disease. Am J Surg Pathol
1992;16:130-7.
- Taylor CR, Shi SR, Cote RJ. Antigen retrieval for immunohistochemistry. Status and need
for greater standardization. Appl Immunohistochem 1996; 4: 144-166.
- Thomas G, Kay EW, Nyhan B, Leader MB. VS38c shows lack of specificity as a marker of
plasma cells. Appl Immunohistochem 1997; 5: 185-188.
- Timens W, Boes A, Vos H, Poppema S. Tissue distribution of the C3d/EBV-receptor: CD21
monoclonal antibodies reactive with a variety of epithelial cells, medullary thymocytes
and peripheral T-cells. Histochemistry 1991;95:605-11.
- Tsang W, Chan J. KP1 (CD68) staining of granular cell neoplasms: is KP1 a marker for
lysosomes rather than the histiocytic lineage? Histopathology 1992;21:84-86.
- Vartanian RK, Sudilovsky D, Weidner N. Immunostaining of monoclonal antibody O13
[anti-MIC2 gene product (CD99)] in lymphomas. Impact of heat-induced epitope retrieval.
Appl Immunohist 1996; 4: 43-55.
- Villuendas R, Piris MA, Orradre JL, Mollejo M, Algara P, Sanchez L, Martinez JC,
Martinez P. P53 protein expression in lymphomas and reactive lymphoid tissue. J Pathol
1992; 166: 235-241.
- Villuendas R, Piris MA, Orradre JL, Mollejo M, Algara P, Sanchez L, Martinez JC,
Martinez P. P53 protein expression in lymphomas and reactive lymphoid tissue. J Pathol
1992; 166: 235-241.
- Veloso JD, Rezuke WN, Cartun RW, Abernathy EC, Pastuszak WT. Immunohistochemical
distinction of follicular lymphoma from follicular hyperplasia in formalin-fixed tissues
using monoclonal antibodies MT2 and bcl-2. Appl Immunohist 1995; 3: 153-159.
- Vyberg M, Nielsen S. Dextran polymer conjugate two-step visualization system for
immunohistochemistry. A comparison of en Vision+ with two three-step avidin-biotin
techniques. Appl Immunohistochem 1998; 6: 3-10.
- Warnke RA, Pulford KA, Pallesen G, et al. Diagnosis of myelomonocytic and macrophage
neoplasms in routinely processed tissue biopsies with monoclonal antileukocyte antibody
KP1. Am J Pathol 1989;135:1089-95.
- Weiss LM, Strickler JG, Medeiros LJ, Gerdes J, Stein H, Warnke RA. Proliferative rates
of non Hodgkin's lymphomas as assessed by Ki-67 antibody. Hum Pathol 1987;18:1155-1159.
- Xerri L, Bouabdallah R, Camerlo J, Hassoun J. Expression of the p53 gene in Hodgkin's
disease: Dissociation between immunohistochemistry and clinicopathological data. Hum
Pathol 1994; 25: 449-454.
- Zarate-Osorno A., Medeiros LJ, Longo DL, Jaffe ES. Non-Hodgkins lymphomas arising
in patients successfully treated for Hodgkins disease: A clinical, histologic, and
immunophenotypic study of 14 cases. Am J Surg Pathol 1992;16:885-895.
- Zukerberg L, Collins A, Ferry J, Harris N. Coexpression of CD15 and CD20 by
Reed-Sternberg cells in Hodgkins disease. Am J Pathol 1991;139:475-483.
- Zukerberg L, Medieros L, Ferry J, Harris N. Diffuse low grade B-cell lymphomas: four
clinically distinct subtypes difined by a combination of morphologic and immunophenotypic
features. Am J Clin Pathol 1993;100:373-385.
Volver al Índice
info@conganat.org
CopyRight Dr.
Tomás Álvaro Naranjo, Dr. Ramón Bosch Príncep, Dra. Salomé Martínez González, Dra.
Mª Teresa Salvadó Usach , 1998.
Última actualización: 01 noviembre 1998 22:08